Andrea S. Blevins Primeau, PhD, MBA

Patients with metastatic cancer are increasingly receiving immunotherapy at the end of their lives, data suggest.

Many patients with nonlocally advanced rectal cancer can safely forgo neoadjuvant radiotherapy, a population-based study suggests.

Adding cyclophosphamide to pomalidomide and dexamethasone improves PFS in Asian patients with relapsed/refractory multiple myeloma, a phase 3 study suggests.

LGBTQ+ cancer patients report higher rates of satisfaction if they receive care in a welcoming environment.

Tarlatamab produced durable responses in patients with relapsed or refractory SCLC in a phase 2 trial.

Researchers sought to assess psychologic distress in patients with indolent non-Hodgkin lymphoma.

Researchers sought to determine whether obinutuzumab administered after HSCT would lead to lower rates of GVHD.

Researchers sought to analyze the clinicopathologic features and genetic alterations of patients with MZL.

Patients who have cancer as an adolescent or young adult may have poor mental health years after diagnosis, a study suggests.

Lung cancer survivors who have never smoked have a similar risk of developing a second primary lung cancer as survivors with a history of smoking, data suggest.